GSE182680,GSE182683 7 V 11 DEXAMETHASONE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182680,GSE182683 7 V 11 DEXAMETHASONE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182680,GSE182683 7 V 11 DEXAMETHASONE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182680,GSE182683 7 V 11 DEXAMETHASONE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182680,GSE182683 7 V 11 DEXAMETHASONE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

MSL complex subunit 3B

Gene

H2A clustered histone 19

Gene

RNA polymerase II subunit J3

Gene

interleukin 9 receptor

Gene

family with sequence similarity 90 member A11

Gene

tandem C2 domains, nuclear

Gene

EEF1A lysine methyltransferase 3

Gene

GTPase, IMAP family member 5

Gene

fucosyltransferase 2 (H blood group)

Gene

islet cell autoantigen 1 like

  • Gene

    MSL complex subunit 3B


  • Gene

    H2A clustered histone 19


  • Gene

    RNA polymerase II subunit J3


  • Gene

    interleukin 9 receptor


  • Gene

    family with sequence similarity 90 member A11


  • Gene

    tandem C2 domains, nuclear


  • Gene

    EEF1A lysine methyltransferase 3


  • Gene

    GTPase, IMAP family member 5


  • Gene

    fucosyltransferase 2 (H blood group)


  • Gene

    islet cell autoantigen 1 like

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.